Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Change in Intangibles (2018 - 2024)

Historic Change in Intangibles for Autolus Therapeutics (AUTL) over the last 3 years, with Q4 2024 value amounting to $12.7 million.

  • Autolus Therapeutics' Change in Intangibles changed N/A to $12.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $13.1 million, marking a year-over-year change of. This contributed to the annual value of $12.7 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Autolus Therapeutics reported Change in Intangibles of $12.7 million as of Q4 2024.
  • In the past 5 years, Autolus Therapeutics' Change in Intangibles ranged from a high of $12.7 million in Q4 2024 and a low of $12.7 million during Q4 2024